A Systematic Review of the Neurocognitive Effects of Psychedelics in Healthy Populations: Implications for Depressive Disorders and Post-Traumatic Stress Disorder.

However, the same group of investigators using a similar dose of MDMA (1.7 mg/kg) and time point measure (75 min post drug) found a statistical trend of worsening selective and sustained attention during the visual Continuous Performance Test (CPT).

also in 1,573 other papers

Psilocybin at 25 mg showed a trend of better performance at day 29, although there was no difference compared to the placebo condition.

also in 33,481 other papers